Without a quorum, the Board could not take action on some rulemaking, though a public hearing on packaging and labeling rules went ahead and a former board member spoke during public comment about 'white labeling.'
Members were prepared for rulemaking at the Board's next public meeting and discussed the limits of support for the legal cannabis industry versus promotion of specific trade groups and businesses.